공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 바이오시밀러 시장 분석(2021년) : 코로나19(COVID-19)에 의한 성장과 변화(-2030년)

Biosimilars Global Market Report 2021: COVID-19 Growth And Change To 2030

리서치사 The Business Research Company
발행일 On Demand Report 상품 코드 1028797
페이지 정보 영문 175 Pages
가격
US $ 5,000 ₩ 5,987,000 PDF (Single User License)
US $ 7,500 ₩ 8,981,000 PDF (Site License)
US $ 10,000 ₩ 11,975,000 PDF (Enterprise License)


세계의 바이오시밀러 시장 분석(2021년) : 코로나19(COVID-19)에 의한 성장과 변화(-2030년) Biosimilars Global Market Report 2021: COVID-19 Growth And Change To 2030
발행일 : On Demand Report 페이지 정보 : 영문 175 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 바이오시밀러(Biosimilars) 시장의 구조와 동향에 대해 분석했으며, 시장의 주요 특징과 구조, 전체적인 시장 규모 및 성장률 동향 전망, 부문별(제품별·용도별)·지역별·주요 국가별 상세 동향, 주요 기업 개요, 최근의 주요 동향, 향후 시장 기회 등에 대해 전해드립니다.

목차

제1장 개요

제2장 바이오시밀러 시장의 특징

제3장 바이오시밀러 시장 동향과 전략

제4장 바이오시밀러 시장에 대한 코로나19(COVID-19)의 영향

제5장 바이오시밀러 시장 : 시장 규모 및 성장률

  • 시장 규모(단위 : 10억 달러, 2015-2020년)
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 시장 규모(단위 : 10억 달러, 2020-2025년, 2030년)
    • 시장 성장 촉진요인
    • 시장 성장 억제요인

제6장 바이오시밀러 시장 : 분야별 분석

  • 제품별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 재조합 비글리코실화 단백질
  • 재조합 글리코실화 단백질
  • 유형별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 인간성장호르몬
  • 에리스로포이에틴
  • 단클론항체
  • 인슐린
  • 인터페론
  • 과립구 집락자극인자(G-CSF)
  • 기타
  • 용도별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 종양
  • 만성질환/자가면역질환
  • 성장호르몬 결핍증
  • 감염증
  • 기타

제7장 바이오시밀러 시장 : 지역별/국가별 분석

  • 지역별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 국가별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)

제8장 아시아태평양의 바이오시밀러 시장

  • 시장 개요
  • 지역 정보
  • 제품별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 용도별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽의 바이오시밀러 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 동유럽의 바이오시밀러 시장

제20장 러시아 시장

제21장 북미의 바이오시밀러 시장

제22장 미국 시장

제23장 남미의 바이오시밀러 시장

제24장 브라질 시장

제25장 중동의 바이오시밀러 시장

제26장 아프리카의 바이오시밀러 시장

제27장 바이오시밀러 시장 : 경쟁 구도와 기업 개요

  • 경쟁 구도
  • 기업 개요
    • Pfizer
    • Amgen
    • Biocon
    • Celltrion
    • Dr. Reddy's Laboratories

제28장 바이오시밀러 파이프라인 제품 분석

제29장 바이오시밀러 시장의 주요 인수합병(M&A)

제30장 바이오시밀러 시장 : 전망과 잠재력 분석

제31장 부록

LSH 21.09.30

“Biosimilars Global Market Report 2021: COVID-19 Growth And Change to 2030” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global biosimilars market.

This report focuses on biosimilars market which is experiencing strong growth. The report gives a guide to the biosimilars market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the biosimilars ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Biosimilars market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider biosimilars market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The biosimilars market section of the report gives context. It compares the biosimilars market with other segments of the biosimilars market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, biosimilars indicators comparison.

Scope

Markets Covered:

1) By Product: Recombinant Non-glycosylated Proteins; Recombinant Glycosylated Proteins

2) By Types: Human Growth Hormone; Erythropoietin; Monoclonal antibodies; Insulin; Interferon; Granulocyte-Colony Stimulating Factor; Others

3) By Application: Oncology; Chronic and Autoimmune Diseases; Growth Hormone Deficiency; Infectious Diseases; Others

Companies Mentioned: Pfizer; Amgen; Biocon; Celltrion; Dr. Reddy's Laboratories

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Biosimilars Market Characteristics

3. Biosimilars Market Trends And Strategies

4. Impact Of COVID-19 On Biosimilars

5. Biosimilars Market Size And Growth

  • 5.1. Global Biosimilars Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Biosimilars Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Biosimilars Market Segmentation

  • 6.1. Global Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Recombinant Non-glycosylated Proteins
  • Recombinant Glycosylated Proteins
  • 6.2. Global Biosimilars Market, Segmentation By Types, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Human Growth Hormone
  • Erythropoietin
  • Monoclonal antibodies
  • Insulin
  • Interferon
  • Granulocyte-Colony Stimulating Factor
  • Others
  • 6.3. Global Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Oncology
  • Chronic and Autoimmune Diseases
  • Growth Hormone Deficiency
  • Infectious Diseases
  • Others

7. Biosimilars Market Regional And Country Analysis

  • 7.1. Global Biosimilars Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Biosimilars Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Biosimilars Market

  • 8.1. Asia-Pacific Biosimilars Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Biosimilars Market

  • 9.1. China Biosimilars Market Overview
  • 9.2. China Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Biosimilars Market

  • 10.1. India Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Biosimilars Market

  • 11.1. Japan Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Biosimilars Market

  • 12.1. Australia Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Biosimilars Market

  • 13.1. Indonesia Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Biosimilars Market

  • 14.1. South Korea Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Biosimilars Market

  • 15.1. Western Europe Biosimilars Market Overview
  • 15.2. Western Europe Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Biosimilars Market

  • 16.1. UK Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Biosimilars Market

  • 17.1. Germany Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Biosimilars Market

  • 18.4. France Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Biosimilars Market

  • 19.1. Eastern Europe Biosimilars Market Overview
  • 19.2. Eastern Europe Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Biosimilars Market

  • 20.1. Russia Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Biosimilars Market

  • 21.1. North America Biosimilars Market Overview
  • 21.2. North America Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Biosimilars Market

  • 22.1. USA Biosimilars Market Overview
  • 22.2. USA Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Biosimilars Market

  • 23.1. South America Biosimilars Market Overview
  • 23.2. South America Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Biosimilars Market

  • 24.1. Brazil Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Biosimilars Market

  • 25.1. Middle East Biosimilars Market Overview
  • 25.2. Middle East Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Biosimilars Market

  • 26.1. Africa Biosimilars Market Overview
  • 26.2. Africa Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Biosimilars Market Competitive Landscape And Company Profiles

  • 27.1. Biosimilars Market Competitive Landscape
  • 27.2. Biosimilars Market Company Profiles
    • 27.2.1. Pfizer
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Amgen
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Biocon
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Celltrion
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Dr. Reddy's Laboratories
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Biosimilars Pipeline Analysis

29. Key Mergers And Acquisitions In The Biosimilars Market

30. Biosimilars Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer
Back to Top
전화 문의
F A Q